Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design
- 23 March 2009
- journal article
- review article
- Published by Wiley in European Journal of Inorganic Chemistry
- Vol. 2009 (10), 1303-1312
- https://doi.org/10.1002/ejic.200900054
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Synthesis, Characterization, and In Vitro Antitumor Activity of New Amidineplatinum(II) Complexes Obtained by Addition of Ammonia to Coordinated AcetonitrileEuropean Journal of Inorganic Chemistry, 2008
- cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsProceedings of the National Academy of Sciences, 2008
- Effects of Geometric Isomerism and Anions on the Kinetics and Mechanism of the Stepwise Formation of Long-Range DNA Interstrand Cross-Links by Dinuclear Platinum Antitumor ComplexesChemistry – A European Journal, 2008
- DNA cleavage and binding selectivity of a heterodinuclear Pt–Cu(3-Clip-Phen) complexJBIC Journal of Biological Inorganic Chemistry, 2008
- New trends for metal complexes with anticancer activityCurrent Opinion in Chemical Biology, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007
- The roles of copper transporters in cisplatin resistanceCancer and Metastasis Reviews, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985